Pegasus Mercantile Inc. is a diversified financial firm specializing as an incubator and venture capital entity focused on early-stage and startup companies. It primarily serves high-growth sectors including global wellness, psychedelics, mycology, hemp, CBD, and healthcare-related industries, particularly those undertaking clinical studies and pioneering research. The company provides financial, operational, and management assistance to target companies, emphasizing scalability and differentiation with the goal of advancing cutting-edge biotechnology research and innovative wellness products. Through strategic investments and partnerships, Pegasus Mercantile aims to facilitate the commercialization of novel treatments, especially in areas addressing pain, depression, and mental illness, leveraging micro-dosing techniques with organic and synthetic compounds. Headquartered in Vancouver, Canada, it operates with a focus on fostering credible, peer-reviewed research alongside navigating legislative and regulatory processes critical to bringing new health solutions to market.